发明授权
- 专利标题： P2X7R antagonists and their use
- 专利标题（中）： P2X7R拮抗剂及其用途
-
申请号： US12758557申请日： 2010-04-12
-
公开(公告)号： US07919503B2公开(公告)日： 2011-04-05
- 发明人: Michael Boes
- 申请人： Michael Boes
- 申请人地址： DE Martinsried
- 专利权人： Affectis Pharmaceuticals AG
- 当前专利权人： Affectis Pharmaceuticals AG
- 当前专利权人地址： DE Martinsried
- 代理机构： Cooley LLP
- 优先权： EP09005324 20090414; EP10156190 20100311
- 主分类号： A61K31/437
- IPC分类号： A61K31/437 ; A61K31/404 ; C07D221/00 ; C07D209/00
摘要：
The present application is directed to novel P2X7R antagonists that are N-indol-3-yl-acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.
公开/授权文献
- US20100267762A1 NOVEL P2X7R ANTAGONISTS AND THEIR USE 公开/授权日：2010-10-21
信息查询
IPC分类:
